Aonong Group(SH:603363) 智通财经网·2026-01-30 11:24Core Viewpoint - Aonong Biological (603363.SH) forecasts a significant decline in net profit for the year 2025, projecting a range of 90 million to 135 million yuan, which represents a decrease of 76.70% to 84.47% compared to the previous year [1] Group 1: Financial Performance - The expected net profit for 2025 is between 90 million and 135 million yuan, a decrease of 44.4345 million to 48.9345 million yuan from the previous year [1] - The decline in profit is attributed to the company's first year post-restructuring, with some assets still not operational, leading to depreciation and amortization costs of approximately 80 million yuan [1] Group 2: Operational Changes - The company has undergone bankruptcy restructuring, significantly reducing its debt and interest expenses year-on-year [1] - Aonong has divested some idle assets and is in the process of resuming operations at its breeding farms, with a rapid recovery in the sow inventory and improved production performance [1] - Major business segments, including pig farming, feed, and slaughtering, have shown signs of recovery and restructuring, solidifying the operational foundation [1] Group 3: Loss Provisions - The company has made provisions for bad debts and asset impairments amounting to approximately 200 million yuan for the year [1] - The benefits from debt restructuring are expected to decline significantly compared to 2024 [1]